The relationship between vascular and metabolic characteristics of primary breast tumours

European Radiology

Volumn 14, Issue 11, 2004, Pages 2038-2045

  Semple, Scott I K ^a   Gilbert, Fiona J ^a   Redpath, Thomas W ^a   Staff, Roger T ^a   Ahearn, Trevor S ^a   Welch, Andrew E ^a   Heys, Steven D ^a   Hutcheon, Andrew W ^b   Smyth, Elizabeth H ^c   Chaturvedi, Shailesh ^c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c NHS GRAMPIAN   (United Kingdom)

Author keywords

Breast cancer; Dynamic MRI; FDG PET; Kinetic modelling

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE;

ADULT; ARTICLE; BREAST CANCER; CALCULATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOSE RESPONSE; DRUG METABOLISM; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; INTERMETHOD COMPARISON; KOLMOGOROV SMIRNOV TEST; LINEAR SYSTEM; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETRIC TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 8344223680     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-004-2454-6     Document Type: Article

References (30)

1. Semple SIK, Gilbert FJ, Redpath TW, Ahearn TS, Welch AE, Hutcheon AW, Heys SD, Smyth EH, Miller ID, Smith IC (2003) Correlation of MRI-PET rim enhancement in breast cancer. A delivery related phenomenon with therapy implications? Lancet Oncol 4:759
2. Heywang SH (1994) Contrast enhanced magnetic resonance imaging of the breast. Invest Radiol 29:94-104
3. Flickinger FW, Allison JD, Sherry RM, Wright JC (1993) Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast-enhanced MRI. J Magn Reson Imaging 11:617-620
4. Tsuboi N, Inomata T, Ogawa Y, Yoshida D, Yoshida S, Moriki T, Kumon M (1999) Changes in the findings of dynamic MRI by preoperative CAF chemotherapy for patients with breast cancer of stage II and III: pathologic correlation. Oncol Rep 6:727-732
5. Kuhl CK (2000) MRI of breast tumors. Eur Radiol 10:46-58
6. Hayes C, Padhani AR, Leach MO (2002) Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 15:154-163
7. Rieber A, Brambs H-J, Gabelmann A, Heilmann V, Keinberg R, Kühn T (2002) Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 12:1711-1719
8. Tofts PS, Berkowitz B, Schnall MD (1995) Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumours using a permeability model. J Magn Reson Med 33:564-568
9. Hoffman U, Brix G, Knopp MV, Heß T, Lorenz WJ (1995) Pharmacokinetic mapping of the breast: A new method for dynamic mammography. J Magn Reson Med 33:506-514
10. Bombardieri E, Crippa F, Maffioli L, Greco M (1997) Nuclear medicine techniques for the study of breast cancer. Eur J Nucl Med 24:809-824
11. Flanagan FL, Dehdashti F, Siegel BA (1998) PET in breast cancer. Semin Nucl Med 28:290-302
12. Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R (1993) Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: Initial evaluation. J Clin Oncol 11:2101-2111
13. Bassa P, Kim EE, Inoue T, Wong FCL, Korkmaz M, Yang DJ, Wong WH, Hicks KW, Buzdar AU, Podoloff DA (1996) Evaluation of preoperative chemotherapy using PET with fluorine-18-flourodeoxyglucose in breast cancer. J Nucl Med 37:931-938
14. 18 F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol 18:1676-1688
15. 18 F] fluorodeoxyglucose PET in the diagnosis of breast cancer: Initial experience. Eur Radiol 11:2058-2070
16. Wienhard K, Eriksson K, Grootoonk S, Casey M, Pietrzyk U, Heiss WD (1992) Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr 16:804-813
17. Semple SIK, Redpath TW, Ahearn TS, Gilbert FJ, Hutcheon AW, Heys SD (2003) Effect of accurate T1 calculation on pharmacokinetic analysis of primary breast cancer. In: Proceedings of the 11th annual meeting of ISMRM, Toronto, Canada
18. Tofts PS, Kermode AG (1991) Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. J Magn Res Med 17:357-3367
19. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ (1991) Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15:621-628
20. Knopp MV, Brix G, Junkermann HJ, Sinn HP (1994) MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin N Am 2:633-658
21. 1-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 10:223-232
22. Ahearn TS (2003) The accuracy and robustness of dynamic contrast enhanced magnetic resonance imaging methodology. Ph.D Thesis, University of Aberdeen, pp 159-174
23. Hathaway PB, Mankoff DA, Maravilla KR, Austin-Seymour MM, Ellis GK, Gralow JR, Cortese AA, Hayes CE, Moe RE (1999) Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: Preliminary experience. Radiology 210:807-814
24. Goerres GW, Michel SCA, Fehr MK, Kaim AH, Steinert HC, Seifert B, von Schulthess GK, Kubik-Huch RA (2003) Follow-up of women with breast cancer: Comparison between MRI and FDG PET. Eur Radiol 13:1635-1644
25. Kim CK, Gupta NC, Chanramouli B, Alavi A (1994) Standardized uptake values of FDG: Body surface area correction is preferable to body weight correction. J Nucl Med 35:164-167
26. Weinmann HJ, Laniado M, Mutzel W (1984) Pharmacokinetics of Gd-DTPA/Dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 16:167-172
27. Williams KV, Bertoldo A, Mattioni B, Price JC, Cobelli C, Kelley DE (2003) Glucose transport and phosphorylation in skeletal muscle in obesity: Insight into a muscle-specific positron emission tomography model. J Clin Endocrinol Metab 88:1271-1279
28. Zasadny KR, Tatsumi M, Wahl RL (2003) FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers. Eur J Nucl Med Mol Imaging 30:274-280
29. Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Charlop A, Lawton TJ, Schubert EK, Tseng J, Livingston RB (2002) Blood flow and metabolism in locally advanced breast cancer: Relationship to response to therapy. J Nucl Med 43:500-509
30. Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Schubert EK, Tseng J, Lawton TJ, Linden HM, Livingston RB (2003) Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J Nucl Med 44:1806-1814